_id
69105368ccc777a4e85d551f
Ticker
COYA
Name
Coya Therapeutics, Inc. Common Stock
Exchange
NASDAQ
Address
5850 San Felipe St., Houston, TX, United States, 77057
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://coyatherapeutics.com
Description
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages in Phase 2 trial for use in the treatment of amyotrophic lateral sclerosis, as well as frontotemporal dementia, Alzheimer's disease (AD), and Parkinson's disease. In addition, the company's pre-clinical product candidates include COYA 301, a low-dose interleukin 2 product candidate to treat AD; COYA 303, an investigational biologic combination of COYA 301 and a glucagon-like-peptide-1 receptor agonist for the treatment of inflammatory diseases; COYA 201, an antigen directed Treg-derived exosome product candidate to treat neurodegenerative, autoimmune, and metabolic diseases; COYA 206, an antigen directed Treg-derived exosome product candidate; and COYA 101. It has a collaboration with Dr. Reddy's Laboratories SA for the development and commercialization of COYA 302, an investigational combination therapy for treatment of amyotrophic lateral sclerosis. Coya Therapeutics, Inc. was founded in 2020 and is headquartered in Houston, Texas.
Last Close
5.49
Volume
161091
Current Price
5.36
Change
0.26
Last Updated
2026-01-02T11:51:31.210Z
Image
data:image/webp;base64,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
Ipo Date
2022-12-29T00:00:00.000Z
Market Cap
121361848
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.998
Sentiment Sources
1
Rating
4.8
Target Price
16.0714
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
3564254
Cost Of Revenue
6840
Gross Profit
3557414
Operating Expenses
5474315
Operating Income
-1916901
Interest Expense
-
Pretax Income
-2115831
Net Income
-2115831
Eps
-0.12644837081926563
Dividends Per Share
-
Shares Outstanding
20924456
Income Tax Expense
-
EBITDA
-2108991
Operating Margin
-53.78126811388862
Total Other Income Expense Net
-198930
Cash
28129866
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
32024810
Property Plant Equipment
18068
Total Assets
32042878
Payables
1111702
Short Term Debt
-
Long Term Debt
-
Total Liabilities
4758387
Equity
27284491
Bs_currency_symbol
USD
Depreciation
6840
Change In Working Capital
-608500
Cash From Operations
-1130603
Capital Expenditures
3
Cash From Investing
-515996
Cash From Financing
19137
Net Change In Cash
-1627462
Cf_currency_symbol
USD
PE
-
PB
3.2871284188515744
ROE
-7.754702112639741
ROA
-6.603124101399381
FCF
-1130606
Fcf Percent
-0.3172069106186035
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
3564254
Quarters > 0 > income Statement > cost Of Revenue
6840
Quarters > 0 > income Statement > gross Profit
3557414
Quarters > 0 > income Statement > operating Expenses
5474315
Quarters > 0 > income Statement > operating Income
-1916901
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-2115831
Quarters > 0 > income Statement > net Income
-2115831
Quarters > 0 > income Statement > eps
-0.12644837081926563
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
16732766
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2108991
Quarters > 0 > income Statement > operating Margin
-53.78126811388862
Quarters > 0 > income Statement > total Other Income Expense Net
-198930
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
28129866
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
32024810
Quarters > 0 > balance Sheet > property Plant Equipment
18068
Quarters > 0 > balance Sheet > total Assets
32042878
Quarters > 0 > balance Sheet > payables
1111702
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4758387
Quarters > 0 > balance Sheet > equity
27284491
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2115831
Quarters > 0 > cash Flow > depreciation
6840
Quarters > 0 > cash Flow > change In Working Capital
-608500
Quarters > 0 > cash Flow > cash From Operations
-1130603
Quarters > 0 > cash Flow > capital Expenditures
3
Quarters > 0 > cash Flow > cash From Investing
-515996
Quarters > 0 > cash Flow > cash From Financing
19137
Quarters > 0 > cash Flow > net Change In Cash
-1627462
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.12644837081926563
Quarters > 0 > ratios > PB
3.2871284188515744
Quarters > 0 > ratios > ROE
-7.754702112639741
Quarters > 0 > ratios > ROA
-6.603124101399381
Quarters > 0 > ratios > FCF
-1130606
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.3172069106186035
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
163616
Quarters > 1 > income Statement > cost Of Revenue
6840
Quarters > 1 > income Statement > gross Profit
156776
Quarters > 1 > income Statement > operating Expenses
6571294
Quarters > 1 > income Statement > operating Income
-6414518
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-6094977
Quarters > 1 > income Statement > net Income
-6094977
Quarters > 1 > income Statement > eps
-0.3644231825917109
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
16724998
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-6088138
Quarters > 1 > income Statement > operating Margin
-3920.4711030706044
Quarters > 1 > income Statement > total Other Income Expense Net
319541
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
29757328
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
33427647
Quarters > 1 > balance Sheet > property Plant Equipment
24908
Quarters > 1 > balance Sheet > total Assets
33452554
Quarters > 1 > balance Sheet > payables
931344
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
5142261
Quarters > 1 > balance Sheet > equity
28310293
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6094977
Quarters > 1 > cash Flow > depreciation
6840
Quarters > 1 > cash Flow > change In Working Capital
-720872
Quarters > 1 > cash Flow > cash From Operations
-5773296
Quarters > 1 > cash Flow > capital Expenditures
4
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-5773296
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.3644231825917109
Quarters > 1 > ratios > PB
3.166551094331662
Quarters > 1 > ratios > ROE
-21.52919081409719
Quarters > 1 > ratios > ROA
-18.21976582116869
Quarters > 1 > ratios > FCF
-5773300
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-35.285668883238806
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
257884
Quarters > 2 > income Statement > cost Of Revenue
5214076
Quarters > 2 > income Statement > gross Profit
-4956192
Quarters > 2 > income Statement > operating Expenses
2720730
Quarters > 2 > income Statement > operating Income
-7676922
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-7306757
Quarters > 2 > income Statement > net Income
-7306757
Quarters > 2 > income Statement > eps
-0.4369808623886131
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
16721000
Quarters > 2 > income Statement > income Tax Expense
720323436
Quarters > 2 > income Statement > EBITDA
-7670082
Quarters > 2 > income Statement > operating Margin
-2976.889609281692
Quarters > 2 > income Statement > total Other Income Expense Net
370165
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
35530624
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
730581
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
38373248
Quarters > 2 > balance Sheet > property Plant Equipment
31748
Quarters > 2 > balance Sheet > total Assets
38404996
Quarters > 2 > balance Sheet > payables
1690007
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
5035439
Quarters > 2 > balance Sheet > equity
33369557
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-7307000
Quarters > 2 > cash Flow > depreciation
6840
Quarters > 2 > cash Flow > change In Working Capital
3391560
Quarters > 2 > cash Flow > cash From Operations
-2828275000
Quarters > 2 > cash Flow > capital Expenditures
50003
Quarters > 2 > cash Flow > cash From Investing
-24975000
Quarters > 2 > cash Flow > cash From Financing
19137000
Quarters > 2 > cash Flow > net Change In Cash
-2809138000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.4369808623886131
Quarters > 2 > ratios > PB
2.6858180946183974
Quarters > 2 > ratios > ROE
-21.89647588069569
Quarters > 2 > ratios > ROA
-19.025537719103003
Quarters > 2 > ratios > FCF
-2828325003
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-10967.431104682726
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1952
Quarters > 3 > income Statement > cost Of Revenue
1937440
Quarters > 3 > income Statement > gross Profit
-1935488
Quarters > 3 > income Statement > operating Expenses
2144806
Quarters > 3 > income Statement > operating Income
-4080294
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-3636063
Quarters > 3 > income Statement > net Income
-2915776
Quarters > 3 > income Statement > eps
-0.17825860487864523
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
16357000
Quarters > 3 > income Statement > income Tax Expense
-720287
Quarters > 3 > income Statement > EBITDA
-4073455
Quarters > 3 > income Statement > operating Margin
-209031.4549180328
Quarters > 3 > income Statement > total Other Income Expense Net
444231
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
38339762
Quarters > 3 > balance Sheet > short Term Investments
38301422238
Quarters > 3 > balance Sheet > receivables
730581
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
44308428
Quarters > 3 > balance Sheet > property Plant Equipment
38588
Quarters > 3 > balance Sheet > total Assets
44347016
Quarters > 3 > balance Sheet > payables
1588128
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
4769921
Quarters > 3 > balance Sheet > equity
39577095
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2915776
Quarters > 3 > cash Flow > depreciation
6840
Quarters > 3 > cash Flow > change In Working Capital
-291380
Quarters > 3 > cash Flow > cash From Operations
-2409767
Quarters > 3 > cash Flow > capital Expenditures
3
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
9692134
Quarters > 3 > cash Flow > net Change In Cash
7282367
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.17825860487864523
Quarters > 3 > ratios > PB
2.2152591037821248
Quarters > 3 > ratios > ROE
-7.367332038897752
Quarters > 3 > ratios > ROA
-6.5749091212811255
Quarters > 3 > ratios > FCF
-2409770
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1234.513319672131
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3554061
Annuals > 0 > income Statement > cost Of Revenue
11865654
Annuals > 0 > income Statement > gross Profit
-8311593
Annuals > 0 > income Statement > operating Expenses
8938118
Annuals > 0 > income Statement > operating Income
-17249711
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-15601074
Annuals > 0 > income Statement > net Income
-14880787
Annuals > 0 > income Statement > eps
-0.9764936675634884
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
15239000
Annuals > 0 > income Statement > income Tax Expense
-720287
Annuals > 0 > income Statement > EBITDA
-17197350
Annuals > 0 > income Statement > operating Margin
-485.3521366121741
Annuals > 0 > income Statement > total Other Income Expense Net
1648637
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
38339762
Annuals > 0 > balance Sheet > short Term Investments
38301422238
Annuals > 0 > balance Sheet > receivables
730581
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
44308428
Annuals > 0 > balance Sheet > property Plant Equipment
38588
Annuals > 0 > balance Sheet > total Assets
44347016
Annuals > 0 > balance Sheet > payables
1588128
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4769921
Annuals > 0 > balance Sheet > equity
39577095
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-14880787
Annuals > 0 > cash Flow > depreciation
27361
Annuals > 0 > cash Flow > change In Working Capital
1876065
Annuals > 0 > cash Flow > cash From Operations
-10288822
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-25000
Annuals > 0 > cash Flow > cash From Financing
16026816
Annuals > 0 > cash Flow > net Change In Cash
5712994
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.9764936675634884
Annuals > 0 > ratios > PB
2.233266489114474
Annuals > 0 > ratios > ROE
-37.599492837966
Annuals > 0 > ratios > ROA
-33.55532872831849
Annuals > 0 > ratios > FCF
-10288822
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2.894948060823942
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
6002206
Annuals > 1 > income Statement > cost Of Revenue
5501527
Annuals > 1 > income Statement > gross Profit
500679
Annuals > 1 > income Statement > operating Expenses
8404028
Annuals > 1 > income Statement > operating Income
-7903349
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-7263984
Annuals > 1 > income Statement > net Income
-7987836
Annuals > 1 > income Statement > eps
-0.7858949232585596
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
10164000
Annuals > 1 > income Statement > income Tax Expense
723852
Annuals > 1 > income Statement > EBITDA
-7332802
Annuals > 1 > income Statement > operating Margin
-131.6740711665011
Annuals > 1 > income Statement > total Other Income Expense Net
639365
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
32626768
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
7500000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
41196325
Annuals > 1 > balance Sheet > property Plant Equipment
65949
Annuals > 1 > balance Sheet > total Assets
41262274
Annuals > 1 > balance Sheet > payables
1155656
Annuals > 1 > balance Sheet > short Term Debt
723852
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5626665
Annuals > 1 > balance Sheet > equity
35635609
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-7987836
Annuals > 1 > cash Flow > depreciation
27361
Annuals > 1 > cash Flow > change In Working Capital
-4643770
Annuals > 1 > cash Flow > cash From Operations
-11188811
Annuals > 1 > cash Flow > capital Expenditures
1
Annuals > 1 > cash Flow > cash From Investing
-543186
Annuals > 1 > cash Flow > cash From Financing
38425063
Annuals > 1 > cash Flow > net Change In Cash
26693066
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.7858949232585596
Annuals > 1 > ratios > PB
1.6542778881651776
Annuals > 1 > ratios > ROE
-22.415320585653525
Annuals > 1 > ratios > ROA
-19.358690701341374
Annuals > 1 > ratios > FCF
-11188812
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.864116626453674
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
4412498
Annuals > 2 > income Statement > gross Profit
-4412498
Annuals > 2 > income Statement > operating Expenses
5399441
Annuals > 2 > income Statement > operating Income
-9811939
Annuals > 2 > income Statement > interest Expense
2433000
Annuals > 2 > income Statement > pretax Income
-12244776
Annuals > 2 > income Statement > net Income
-12244776
Annuals > 2 > income Statement > eps
-1.2308886837090989
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
9947915
Annuals > 2 > income Statement > income Tax Expense
2433000
Annuals > 2 > income Statement > EBITDA
-9259578
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-2432837
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5933702
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
7184966
Annuals > 2 > balance Sheet > property Plant Equipment
93310
Annuals > 2 > balance Sheet > total Assets
8395566
Annuals > 2 > balance Sheet > payables
1815270
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
12965480
Annuals > 2 > balance Sheet > total Liabilities
16789111
Annuals > 2 > balance Sheet > equity
-8393545
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-12244776
Annuals > 2 > cash Flow > depreciation
27361
Annuals > 2 > cash Flow > change In Working Capital
751838
Annuals > 2 > cash Flow > cash From Operations
-7239354
Annuals > 2 > cash Flow > capital Expenditures
4
Annuals > 2 > cash Flow > cash From Investing
-525000
Annuals > 2 > cash Flow > cash From Financing
9357878
Annuals > 2 > cash Flow > net Change In Cash
1593524
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.2308886837090989
Annuals > 2 > ratios > PB
-6.874080856181744
Annuals > 2 > ratios > ROE
145.88324718578383
Annuals > 2 > ratios > ROA
-145.84812983424823
Annuals > 2 > ratios > FCF
-7239358
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
16133
Annuals > 3 > income Statement > gross Profit
-16133
Annuals > 3 > income Statement > operating Expenses
4870310
Annuals > 3 > income Statement > operating Income
-4870310
Annuals > 3 > income Statement > interest Expense
21482
Annuals > 3 > income Statement > pretax Income
-4891792
Annuals > 3 > income Statement > net Income
-4891792
Annuals > 3 > income Statement > eps
-0.7408306197163219
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
6603118
Annuals > 3 > income Statement > income Tax Expense
-21482
Annuals > 3 > income Statement > EBITDA
-4854177
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-21482
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4340178
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
4584258
Annuals > 3 > balance Sheet > property Plant Equipment
120671
Annuals > 3 > balance Sheet > total Assets
4792110
Annuals > 3 > balance Sheet > payables
857567
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1148383
Annuals > 3 > balance Sheet > equity
3643727
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-4891792
Annuals > 3 > cash Flow > depreciation
16133
Annuals > 3 > cash Flow > change In Working Capital
739169
Annuals > 3 > cash Flow > cash From Operations
-3903268
Annuals > 3 > cash Flow > capital Expenditures
136804
Annuals > 3 > cash Flow > cash From Investing
-136804
Annuals > 3 > cash Flow > cash From Financing
-340584
Annuals > 3 > cash Flow > net Change In Cash
-4380656
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.7408306197163219
Annuals > 3 > ratios > PB
10.51068985135275
Annuals > 3 > ratios > ROE
-134.25242890040886
Annuals > 3 > ratios > ROA
-102.0801275429821
Annuals > 3 > ratios > FCF
-4040072
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.12644837081926563
Valuation > metrics > PB
3.2871284188515744
Valuation > final Score
47.128715811484255
Valuation > verdict
9.6% Overvalued
Profitability > metrics > ROE
-7.754702112639741
Profitability > metrics > ROA
-6.606849501995485
Profitability > metrics > Net Margin
-0.5936252017953827
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.17439896533162375
Risk > metrics > Interest Coverage
-280.24868421052633
Risk > final Score
-1061
Risk > verdict
High
Liquidity > metrics > Current Ratio
28.807009432383857
Liquidity > metrics > Quick Ratio
28.807009432383857
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
48.33448905668338
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-3692
Prev Risks > 1
-25
Prev Risks > 2
23
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:38:48.115Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.13
Earnings History > 0 > eps Estimate
-0.59
Earnings History > 0 > eps Difference
0.46
Earnings History > 0 > surprise Percent
77.9661
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.36
Earnings History > 1 > eps Estimate
0.13
Earnings History > 1 > eps Difference
-0.49
Earnings History > 1 > surprise Percent
-376.9231
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.44
Earnings History > 2 > eps Estimate
-0.46
Earnings History > 2 > eps Difference
0.02
Earnings History > 2 > surprise Percent
4.3478
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-18
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.18
Earnings History > 3 > eps Estimate
-0.4
Earnings History > 3 > eps Difference
0.22
Earnings History > 3 > surprise Percent
55
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-06
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.26
Earnings History > 4 > eps Estimate
-0.36
Earnings History > 4 > eps Difference
0.1
Earnings History > 4 > surprise Percent
27.7778
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-12
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.19
Earnings History > 5 > eps Estimate
0.23
Earnings History > 5 > eps Difference
-0.42
Earnings History > 5 > surprise Percent
-182.6087
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.35
Earnings History > 6 > eps Estimate
-0.29
Earnings History > 6 > eps Difference
-0.06
Earnings History > 6 > surprise Percent
-20.6897
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-19
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.28
Earnings History > 7 > eps Estimate
0.26
Earnings History > 7 > eps Difference
0.02
Earnings History > 7 > surprise Percent
7.6923
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-08
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.48
Earnings History > 8 > eps Estimate
-0.37
Earnings History > 8 > eps Difference
-0.11
Earnings History > 8 > surprise Percent
-29.7297
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-08
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.31
Earnings History > 9 > eps Estimate
-0.32
Earnings History > 9 > eps Difference
0.01
Earnings History > 9 > surprise Percent
3.125
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.28
Earnings History > 10 > eps Estimate
-0.43
Earnings History > 10 > eps Difference
0.15
Earnings History > 10 > surprise Percent
34.8837
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-29
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.3124
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-12-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.2
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.2
Earnings History > 12 > surprise Percent
-
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages in Phase 2 trial for use in the treatment of amyotrophic lateral sclerosis, as well as frontotemporal dementia, Alzheimer's disease (AD), and Parkinson's disease. In addition, the company's pre-clinical product candidates include COYA 301, a low-dose interleukin 2 product candidate to treat AD; COYA 303, an investigational biologic combination of COYA 301 and a glucagon-like-peptide-1 receptor agonist for the treatment of inflammatory diseases; COYA 201, an antigen directed Treg-derived exosome product candidate to treat neurodegenerative, autoimmune, and metabolic diseases; COYA 206, an antigen directed Treg-derived exosome product candidate; and COYA 101. It has a collaboration with Dr. Reddy's Laboratories SA for the development and commercialization of COYA 302, an investigational combination therapy for treatment of amyotrophic lateral sclerosis. Coya Therapeutics, Inc. was founded in 2020 and is headquartered in Houston, Texas.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AD. Boral Capital Reiterates Buy Rating for Coya Therapeutics (NASDAQ:COYA) MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$16.0714
Analyst Picks
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Coya Therapeutics, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.13
EPS Estimate
-0.59
EPS Difference
0.46
Surprise Percent
77.9661%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.